Sinocare Salute del bilancio

Salute finanziaria criteri di controllo 5/6

Sinocare ha un patrimonio netto totale di CN¥3.6B e un debito totale di CN¥981.8M, che porta il suo rapporto debito/patrimonio netto a 27.5%. Le sue attività totali e le sue passività totali sono rispettivamente CN¥5.9B e CN¥2.4B. L'EBIT di Sinocare è CN¥385.7M rendendo il suo rapporto di copertura degli interessi 13.5. Ha liquidità e investimenti a breve termine pari a CN¥845.4M.

Informazioni chiave

27.5%

Rapporto debito/patrimonio netto

CN¥981.81m

Debito

Indice di copertura degli interessi	13.5x
Contanti	CN¥845.42m
Patrimonio netto	CN¥3.58b
Totale passività	CN¥2.36b
Totale attività	CN¥5.93b

Aggiornamenti recenti sulla salute finanziaria

Is Sinocare (SZSE:300298) Using Too Much Debt?

Nov 17

Is Sinocare (SZSE:300298) A Risky Investment?

Jun 07

Recent updates

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( CN¥2.2B ) di 300298 superano le sue passività a breve termine ( CN¥1.6B ).

Passività a lungo termine: Le attività a breve termine di 300298 ( CN¥2.2B ) superano le sue passività a lungo termine ( CN¥797.1M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: Il rapporto debito netto/patrimonio netto ( 3.8% ) di 300298 è considerato soddisfacente.

Riduzione del debito: Il rapporto debito/patrimonio netto di 300298 è aumentato da 5.9% a 27.5% negli ultimi 5 anni.

Copertura del debito: Il debito di 300298 è ben coperto dal flusso di cassa operativo ( 74.2% ).

Copertura degli interessi: I pagamenti degli interessi sul debito di 300298 sono ben coperti dall'EBIT ( 13.5 x copertura).

Sinocare Salute del bilancio

Salute finanziaria criteri di controllo 5/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Is Sinocare (SZSE:300298) Using Too Much Debt?

Is Sinocare (SZSE:300298) A Risky Investment?

Recent updates

Is Sinocare (SZSE:300298) Using Too Much Debt?

We Think You Can Look Beyond Sinocare's (SZSE:300298) Lackluster Earnings

Consensus EPS estimates fall by 11%

New minor risk - Profit margin trend

Estimating The Intrinsic Value Of Sinocare Inc. (SZSE:300298)

Investor sentiment deteriorates as stock falls 15%

Sinocare (SZSE:300298) Is Reinvesting At Lower Rates Of Return

New minor risk - Share price stability

Sinocare Inc. to Report Q3, 2024 Results on Oct 24, 2024

Now 21% overvalued after recent price rise

Investor sentiment improves as stock rises 15%

Second quarter 2024 earnings released: EPS: CN¥0.21 (vs CN¥0.19 in 2Q 2023)

Sinocare Inc.'s (SZSE:300298) Price Is Out Of Tune With Earnings

Calculating The Intrinsic Value Of Sinocare Inc. (SZSE:300298)

Sinocare Inc. to Report First Half, 2024 Results on Aug 29, 2024

Sinocare Inc. Announces Dividend Implementation for 2023, Payable on 17 June 2024

Is Sinocare (SZSE:300298) A Risky Investment?

Sinocare's (SZSE:300298) Soft Earnings Don't Show The Whole Picture

Price target decreased by 8.0% to CN¥31.01

Sinocare Inc., Annual General Meeting, May 21, 2024

Sinocare Inc. Proposes Final Dividend for 2023

First quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.12 in 1Q 2023)

Investor sentiment improves as stock rises 16%

Sinocare Inc.'s (SZSE:300298) P/E Is On The Mark

Now 21% undervalued after recent price drop

Here's What To Make Of Sinocare's (SZSE:300298) Decelerating Rates Of Return

Sinocare Inc. to Report Q1, 2024 Results on Apr 26, 2024

Now 21% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 16%

Sinocare Inc. to Report Fiscal Year 2023 Results on Apr 26, 2024

Investor sentiment improves as stock rises 24%

Third quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.28 in 3Q 2022)

Now 20% undervalued

Sinocare Inc. to Report Q3, 2023 Results on Oct 24, 2023

Now 20% undervalued after recent price drop

Price target decreased by 14% to CN¥33.71

Second quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.26 in 2Q 2022)

Sinocare Inc. (SZSE:300298) announces an Equity Buyback for CNY 150 million worth of its shares.

Sinocare Inc. (SZSE:300298) announces an Equity Buyback for CNY 150 million worth of its shares.

Now 21% undervalued after recent price drop

Investor sentiment improves as stock rises 17%

Sinocare Inc. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 26 May 2023

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Price target increased to CN¥39.34

Sinocare Inc. Approves Board Elections

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.28 (vs CN¥0.14 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.26 (vs CN¥0.13 in 2Q 2021)

Sinocare Inc. Approves Cash Dividend for the Year 2021

Investor sentiment improved over the past week

Consensus forecasts updated

Price target decreased to CN¥20.73

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

High number of new directors

Sinocare Inc., Annual General Meeting, May 13, 2022

Sinocare Inc. Proposes Cash Dividend for 2021

Third quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.16 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.17 in 2Q 2020)

Price target decreased to CN¥40.66

Consensus forecasts updated

First quarter 2021 earnings released: EPS CN¥0.079 (vs CN¥0.11 in 1Q 2020)

Investor sentiment deteriorated over the past week

New 90-day low: CN¥31.87

Sinocare Inc. to Report Fiscal Year 2020 Results on Apr 17, 2021

New 90-day high: CN¥46.30

Third quarter earnings released

Sinocare Inc. to Report Q3, 2020 Results on Oct 17, 2020

Earnings released

Sinocare Inc. to Report First Half, 2020 Results on Aug 07, 2020

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane